Skinvisible (SKVI) Retained Earnings (2010 - 2026)
Skinvisible's (SKVI) quarterly Retained Earnings came in at -$41.5 million in Q2 2026, down 2.55% year-over-year from -$42.6 million in Q2 2025, and down 0.62% quarter-over-quarter from -$41.3 million in Q1 2026.
Analysis
Skinvisible (SKVI) Retained Earnings (2010 - 2026) Analysis & Trends
Skinvisible has disclosed Retained Earnings across 17 years of filings, most recently posting -$41.5 million for Q2 2026.
- In Q2 2026, Retained Earnings fell 2.55% year-over-year to -$41.5 million; the TTM figure through Jun 2026 stood at -$41.5 million (down 2.55% YoY), while the FY2025 annual figure was -$41.0 million, down 2.66% from the prior year.
- Retained Earnings came in at -$41.5 million for Q2 2026 at Skinvisible, down from -$41.3 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of -$36.0 million in Q1 2022 to a low of -$41.5 million in Q2 2026.
- Average Retained Earnings over 5 years is -$39.3 million, with a median of -$39.8 million recorded in 2024.
- Year-over-year, Retained Earnings slipped 7.21% in 2023 and slipped 1.22% in 2025.
- Over 5 years, Retained Earnings stood at -$37.0 million in 2022, then decreased by 6.44% to -$39.4 million in 2023, then retreated by 1.44% to -$39.9 million in 2024, then retreated by 2.66% to -$41.0 million in 2025, then fell by 1.27% to -$41.5 million in 2026.
- Per Business Quant data, the three most recent Retained Earnings figures were -$41.5 million in Q2 2026, -$41.3 million in Q1 2026, and -$41.0 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 647.06 Bn | 626.30 Bn | 17.26 Bn | 171.67 Bn |
| 2 | AbbVie | 440.06 Bn | 433.49 Bn | 12.70 Bn | -17.33 Bn |
| 3 | Merck | 364.19 Bn | 357.05 Bn | 12.21 Bn | 63.27 Bn |
| 4 | Novartis Ag | 268.45 Bn | 260.76 Bn | 11.24 Bn | 40.86 Bn |
| 5 | Pfizer | 158.40 Bn | 146.70 Bn | 10.94 Bn | 112.09 Bn |
| 6 | Sanofi | 52.57 Bn | 45.19 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 44.32 Bn | 44.32 Bn | - | -4.00 Bn |
| 8 | Incyte | 24.98 Bn | 20.44 Bn | 1.57 Bn | 1.10 Bn |
| 9 | United Therapeutics | 21.15 Bn | 18.49 Bn | 683.80 Mn | 9.16 Bn |
| 10 | Skinvisible | 1.08 Mn | 1.08 Mn | 5,000.00 | -41.53 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -41.53 Mn |
| Mar 31, 2026 | -41.28 Mn |
| Dec 31, 2025 | -41.01 Mn |
| Sep 30, 2025 | -40.75 Mn |
| Jun 30, 2025 | -40.50 Mn |
| Mar 31, 2025 | -40.23 Mn |
| Dec 31, 2024 | -39.95 Mn |
| Sep 30, 2024 | -40.26 Mn |
| Jun 30, 2024 | -39.97 Mn |
| Mar 31, 2024 | -39.67 Mn |
| Dec 31, 2023 | -39.38 Mn |
| Sep 30, 2023 | -39.08 Mn |
| Jun 30, 2023 | -38.79 Mn |
| Mar 31, 2023 | -38.51 Mn |
| Dec 31, 2022 | -37.00 Mn |
| Sep 30, 2022 | -36.60 Mn |
| Jun 30, 2022 | -36.18 Mn |
| Mar 31, 2022 | -35.99 Mn |
| Dec 31, 2021 | -35.77 Mn |
| Sep 30, 2021 | -35.61 Mn |